Immunization strategies to block the herpes simplex virus type 1 immunoglobulin G Fc receptor.
about
Blocking antibody access to neutralizing domains on glycoproteins involved in entry as a novel mechanism of immune evasion by herpes simplex virus type 1 glycoproteins C and EReplication of herpes simplex virus: egress of progeny virus at specialized cell membrane sites.Surface engineering of quantum dots for in vivo vascular imaging.Identification of Plasmodium falciparum var1CSA and var2CSA domains that bind IgM natural antibodies.Blocking herpes simplex virus 2 glycoprotein E immune evasion as an approach to enhance efficacy of a trivalent subunit antigen vaccine for genital herpes.Herpes simplex virus type 2 glycoprotein E is required for efficient virus spread from epithelial cells to neurons and for targeting viral proteins from the neuron cell body into axons.Herpes simplex virus type 1 glycoprotein e is required for axonal localization of capsid, tegument, and membrane glycoproteins.The herpes simplex virus 1 IgG fc receptor blocks antibody-mediated complement activation and antibody-dependent cellular cytotoxicity in vivo.Direct and specific binding of the UL16 tegument protein of herpes simplex virus to the cytoplasmic tail of glycoprotein E.Prospects for developing an effective vaccine against ocular herpes simplex virus infection.Anterograde spread of herpes simplex virus type 1 requires glycoprotein E and glycoprotein I but not Us9.Immunization with HSV-1 glycoprotein C prevents immune evasion from complement and enhances the efficacy of an HSV-1 glycoprotein D subunit vaccineElucidation of the block to herpes simplex virus egress in the absence of tegument protein UL16 reveals a novel interaction with VP22.Short interfering RNA-mediated inhibition of herpes simplex virus type 1 gene expression and function during infection of human keratinocytes.Molecular association of herpes simplex virus type 1 glycoprotein E with membrane protein Us9.
P2860
Q24646778-F4638DC5-C9FF-4855-8B1C-BF0D19929BF2Q30423181-0C317F51-3516-4CCC-B80B-708490C78260Q33782729-2F0EC2C6-D9BE-4359-9257-BE76951B0D2DQ33849078-9524E55E-6C8D-4A73-BFFA-AB2BA457A99EQ34057952-5D6AD5EE-778D-4C5E-B0D4-53DE001D665EQ34071917-2441C1CD-2AC9-493B-B0A9-08A1979DD3A8Q34092761-DA88ED29-A026-4DA8-901F-BBC305A9D964Q34742635-44842180-75AD-407A-A005-43E3DFAAEC08Q35192739-1DB5880A-A06A-4B98-BCF1-41CFD68A24F0Q36311038-2240FDAC-61BF-4A4D-84A2-2E9456A2BE28Q37333821-93C109E3-D217-4155-BB24-6B11CF73D255Q37439603-9B5DD9DB-A4C8-422E-84D2-978D402290DCQ37547818-34E8DB21-EE88-4412-A7FE-1091A6236636Q39992106-930CAFEA-2CBC-4C6F-A5DD-EE62613D9432Q40560838-4948CB89-B678-4BF2-959C-D853244B8A45
P2860
Immunization strategies to block the herpes simplex virus type 1 immunoglobulin G Fc receptor.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Immunization strategies to blo ...... immunoglobulin G Fc receptor.
@en
type
label
Immunization strategies to blo ...... immunoglobulin G Fc receptor.
@en
prefLabel
Immunization strategies to blo ...... immunoglobulin G Fc receptor.
@en
P2093
P2860
P1433
P1476
Immunization strategies to blo ...... immunoglobulin G Fc receptor.
@en
P2093
Harvey M Friedman
John M Lubinski
Xiaoqing Lin
P2860
P304
P356
10.1128/JVI.78.5.2562-2571.2004
P407
P577
2004-03-01T00:00:00Z